The U.K. regulatory authority approved the Alzheimer's disease drug, Leqembi, last month. But the U.K. cost-effectiveness ...

“I remember a couple instances in which she went to hit me with a cane,” says Elizabeth Edgerly, the senior director of care ...

BYU linebacker Ben Bywater added a risky procedure in Tijuana during his shoulder recovery. Now he is medically retired from ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...

Our Paradigm Peptides review discusses why they closed in the first place, and 3 great alternative companies to buy from. You ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 626.12% and ...

So, taking this can help protect your memory and guide against diseases that hurt the brain like dementia. This mushroom also ...

A recent study has shown that people who take SGLT-2 inhibitors for type 2 diabetes management have a 35% lower diabetes risk ...

It's rare - miraculously rare - that a drug can have such a pronounced effect that its immediate benefits translate into ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

PRICEVILLE — Priceville’s new drug and search dog has arrived in town after a three-month wait and after one week on the job ...

The Egyptian embassy in the Hague has received three ancient artefacts - an Ushabti statuette, a part of a painted coffin, and a mummy's head from the Late Period - that were smuggled out of the ...